Logo image of CYR.DE

CYAN AG (CYR.DE) Stock Fundamental Analysis

Europe - FRA:CYR - DE000A2E4SV8 - Common Stock

2.26 EUR
+0.02 (+0.89%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

3

Overall CYR gets a fundamental rating of 3 out of 10. We evaluated CYR against 104 industry peers in the Software industry. While CYR seems to be doing ok healthwise, there are quite some concerns on its profitability. CYR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CYR had negative earnings in the past year.
In the past year CYR has reported a negative cash flow from operations.
In the past 5 years CYR always reported negative net income.
CYR had a negative operating cash flow in each of the past 5 years.
CYR.DE Yearly Net Income VS EBIT VS OCF VS FCFCYR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

CYR has a Return On Assets of -11.43%. This is in the lower half of the industry: CYR underperforms 76.70% of its industry peers.
With a Return On Equity value of -13.30%, CYR is not doing good in the industry: 67.96% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.43%
ROE -13.3%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYR.DE Yearly ROA, ROE, ROICCYR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

CYR has a Gross Margin of 81.83%. This is in the better half of the industry: CYR outperforms 73.79% of its industry peers.
In the last couple of years the Gross Margin of CYR has declined.
CYR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.24%
GM growth 5Y-3.74%
CYR.DE Yearly Profit, Operating, Gross MarginsCYR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

5

2. Health

2.1 Basic Checks

CYR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CYR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CYR.DE Yearly Shares OutstandingCYR.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
CYR.DE Yearly Total Debt VS Total AssetsCYR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 7.08 indicates that CYR is not in any danger for bankruptcy at the moment.
CYR's Altman-Z score of 7.08 is fine compared to the rest of the industry. CYR outperforms 78.64% of its industry peers.
CYR has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
CYR has a Debt to Equity ratio of 0.06. This is in the better half of the industry: CYR outperforms 79.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 7.08
ROIC/WACCN/A
WACC7.34%
CYR.DE Yearly LT Debt VS Equity VS FCFCYR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.92 indicates that CYR should not have too much problems paying its short term obligations.
The Current ratio of CYR (1.92) is better than 74.76% of its industry peers.
A Quick Ratio of 1.91 indicates that CYR should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.91, CYR is doing good in the industry, outperforming 76.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.91
CYR.DE Yearly Current Assets VS Current LiabilitesCYR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

CYR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.21%, which is quite impressive.
The Revenue has grown by 135.32% in the past year. This is a very strong growth!
CYR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -23.31% yearly.
EPS 1Y (TTM)81.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.06%
Revenue 1Y (TTM)135.32%
Revenue growth 3Y-5.78%
Revenue growth 5Y-23.31%
Sales Q2Q%308.74%

3.2 Future

The Earnings Per Share is expected to grow by 33.60% on average over the next years. This is a very strong growth
CYR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.98% yearly.
EPS Next Y64.71%
EPS Next 2Y40.38%
EPS Next 3Y18.24%
EPS Next 5Y33.6%
Revenue Next Year28.88%
Revenue Next 2Y25.88%
Revenue Next 3Y37.87%
Revenue Next 5Y19.98%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CYR.DE Yearly Revenue VS EstimatesCYR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10M 20M 30M
CYR.DE Yearly EPS VS EstimatesCYR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CYR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CYR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYR.DE Price Earnings VS Forward Price EarningsCYR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYR.DE Per share dataCYR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as CYR's earnings are expected to grow with 18.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.38%
EPS Next 3Y18.24%

More info and screens

0

5. Dividend

5.1 Amount

CYR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYAN AG

FRA:CYR (9/19/2025, 7:00:00 PM)

2.26

+0.02 (+0.89%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)09-25 2025-09-25
Inst Owners1.59%
Inst Owner ChangeN/A
Ins Owners36.92%
Ins Owner ChangeN/A
Market Cap45.63M
Analysts83.33
Price Target3.53 (56.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.43
P/FCF N/A
P/OCF N/A
P/B 1.62
P/tB 20.91
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0.35
BVpS1.39
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.43%
ROE -13.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.83%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.24%
GM growth 5Y-3.74%
F-Score3
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.16%
Cap/Sales 0.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.91
Altman-Z 7.08
F-Score3
WACC7.34%
ROIC/WACCN/A
Cap/Depr(3y)16.18%
Cap/Depr(5y)14.33%
Cap/Sales(3y)12.45%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.06%
EPS Next Y64.71%
EPS Next 2Y40.38%
EPS Next 3Y18.24%
EPS Next 5Y33.6%
Revenue 1Y (TTM)135.32%
Revenue growth 3Y-5.78%
Revenue growth 5Y-23.31%
Sales Q2Q%308.74%
Revenue Next Year28.88%
Revenue Next 2Y25.88%
Revenue Next 3Y37.87%
Revenue Next 5Y19.98%
EBIT growth 1Y-76.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year94.87%
EBIT Next 3Y55.63%
EBIT Next 5Y31.35%
FCF growth 1Y19.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.23%
OCF growth 3YN/A
OCF growth 5YN/A